You are viewing a javascript disabled version of the site. Please enable Javascript for this site to function properly.
Go to headerGo to navigationGo to searchGo to contentsGo to footer
In content section. Select this link to jump to navigation

Amyloid-β and Mitochondria in Aging and Alzheimer's Disease: Implications for Synaptic Damage and Cognitive Decline

Issue title: Mitochondria and Neurodegenerative Diseases

Guest editors: Xiongwei Zhu, M. Flint Beal, Xinglong Wang, George Perry and Mark A. Smith

Article type: Review Article

Authors: Reddy, P. Hemachandraa; b; * | Manczak, Mariaa | Mao, Peizhonga | Calkins, Marcus J.a | Reddy, Arubala P.a | Shirendeb, Ulziibata

Affiliations: [a] Neurogenetics Laboratory, Division of Neuroscience, Oregon National Primate Research Center, Beaverton, OR, USA | [b] Department of Physiology and Pharmacology, Oregon Health & Science University, Portland, OR, USA

Correspondence: [*] Correspondence to: P. Hemachandra Reddy, PhD, Neurogenetics Laboratory, Neuroscience Division, Oregon National Primate Research Center, West Campus, Oregon Health & Science University, 505 NW 185{th} Avenue, Beaverton, OR 97006, USA. Tel.: +1 503 418 2625; Fax: +1 503 418 2501; E-mail: reddyh@ohsu.edu.

Keywords: Amyloid-β, amyloid-β precursor protein, mitochondrial therapeutics, synaptic pathology

DOI: 10.3233/JAD-2010-100504

Journal: Journal of Alzheimer's Disease, vol. 20, no. s2, pp. S499-S512, 2010

Accepted 18 April 2010
|
Published: 3 June 2010
Get PDF open access

Abstract

This article reviews the role of amyloid-β (Aβ) and mitochondria in synaptic damage and cognitive decline found in patients with Alzheimer's disease (AD). Recent molecular, cellular, animal model, and postmortem brain studies have revealed that Aβ and mitochondrial abnormalities are key factors that cause synaptic damage and cognitive decline in AD. Aβ is reported to accumulate in subcellular compartments and to impair the normal function of neurons in AD patients. Further, recent studies using biochemical methods and electron microscopy have revealed that the accumulation of Aβ at nerve terminals affect synaptic activities, including the release of neurotransmitters and synaptic vesicles. Recent studies of the relationship between mitochondria and Aβ in AD patients suggest that in mitochondria, structural changes caused by Aβ result in increased mitochondrial fragmentation, decreased mitochondrial fusion, mitochondrial dysfunction, and synaptic damage. This paper discusses the latest research on Aβ, mitochondria, age-dependent factors of AD in the brain, and synaptic damage in AD. This paper also briefly discusses potential mitochondrial therapeutics in the treatment of patients with AD.

Show more